How do you administer benzocaine (local anesthetic)/menthol lozenges?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To administer benzocaine/menthol lozenges, allow one lozenge to dissolve slowly in your mouth when needed for sore throat or mouth pain, but be aware of the potential risk of methemoglobinemia, a life-threatening adverse event associated with benzocaine use, as reported in a study published in Gastroenterology 1. When using these lozenges, it is essential to follow the recommended dosage and administration guidelines to minimize the risk of adverse events.

  • Typically, you can use one lozenge every 2 hours as needed, but don't exceed more than 10 lozenges in a 24-hour period.
  • Do not chew or swallow the lozenge whole, as this can increase the risk of methemoglobinemia.
  • The lozenges work through two active ingredients: benzocaine, which is a local anesthetic that numbs the area, and menthol, which provides a cooling sensation that helps relieve discomfort.
  • Before using, check the package for specific dosing instructions as concentrations may vary between products.
  • If you have persistent throat pain lasting more than 2 days, develop fever, rash, or irritation, or if swallowing becomes difficult, discontinue use and consult a healthcare provider, as these symptoms may indicate a more serious condition that requires medical attention.
  • These lozenges are not recommended for children under 5 years old, and you should avoid eating or drinking for 15 minutes after using them to allow the medication to work effectively. It is crucial to be aware of the signs and symptoms of methemoglobinemia, such as cyanosis despite adequate supplemental oxygen delivery, and to seek medical attention immediately if you experience any of these symptoms, as treatment with intravenous methylene blue may be necessary, as described in the study published in Gastroenterology 1.

From the Research

Administration of Benzocaine/Menthol Lozenges

To administer benzocaine (local anesthetic)/menthol lozenges, the following steps can be considered:

  • Suck the lozenge slowly in the mouth, allowing it to dissolve and release the active ingredients [ 2 ].
  • The lozenge should be allowed to dissolve completely in the mouth, providing longer contact time of the drug with the naso-pharyngeal mucosa [ 3 ].
  • It is essential to follow the recommended dosage and administration instructions to minimize the risk of adverse events, such as methemoglobinemia [ 4, 5 ].

Important Considerations

  • Benzocaine lozenges can be effective in reducing painful pharyngeal discomfort, with significant decreases in pain intensity compared to placebo [ 2 ].
  • The use of benzocaine lozenges may be associated with a risk of methemoglobinemia, a condition characterized by abnormal levels of oxidized hemoglobin [ 4, 5 ].
  • Health professionals should be aware of the potential risks and benefits of benzocaine lozenges and monitor patients for any adverse events [ 4 ].

Bioequivalence and In Vitro Testing

  • The bioequivalence of locally acting lozenges can be evaluated using in vivo parameters, such as sucking times, saliva osmolality, and salivary flow rates [ 6 ].
  • In vitro test methods, such as dissolution testing, can be used to predict the bioequivalence of lozenges, but may not accurately reflect in vivo conditions [ 6 ].

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Efficacy of a benzocaine lozenge in the treatment of uncomplicated sore throat.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2012

Research

Lozenges as delivery system for upper respiratory catarrh medication.

Recent patents on drug delivery & formulation, 2014

Research

Bioequivalence of locally acting lozenges: Evaluation of critical in vivo parameters and first steps towards a bio-predictive in vitro test method.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.